Unknown

Dataset Information

0

Dapl1 controls NFATc2 activation to regulate CD8+ T cell exhaustion and responses in chronic infection and cancer.


ABSTRACT: CD8+ T cells are central mediators of immune responses against infections and cancer. Here we identified Dapl1 as a crucial regulator of CD8+ T cell responses to cancer and infections. Dapl1 deficiency promotes the expansion of tumour-infiltrating effector memory-like CD8+ T cells and prevents their functional exhaustion, coupled with increased antitumour immunity and improved efficacy of adoptive T cell therapy. Dapl1 controls activation of NFATc2, a transcription factor required for the effector function of CD8+ T cells. Although NFATc2 mediates induction of the immune checkpoint receptor Tim3, competent NFATc2 activation prevents functional exhaustion of CD8+ T cells. Interestingly, exhausted CD8+ T cells display attenuated NFATc2 activation due to Tim3-mediated feedback inhibition; Dapl1 deletion rescues NFATc2 activation and thereby prevents dysfunction of exhausted CD8+ T cells in chronic infection and cancer. These findings establish Dapl1 as a crucial regulator of CD8+ T cell immunity and a potential target for cancer immunotherapy.

SUBMITTER: Zhu L 

PROVIDER: S-EPMC9704754 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Dapl1 controls NFATc2 activation to regulate CD8<sup>+</sup> T cell exhaustion and responses in chronic infection and cancer.

Zhu Lele L   Zhou Xiaofei X   Gu Meidi M   Kim Jiseong J   Li Yanchuan Y   Ko Chun-Jung CJ   Xie Xiaoping X   Gao Tianxiao T   Cheng Xuhong X   Sun Shao-Cong SC  

Nature cell biology 20220630 7


CD8<sup>+</sup> T cells are central mediators of immune responses against infections and cancer. Here we identified Dapl1 as a crucial regulator of CD8<sup>+</sup> T cell responses to cancer and infections. Dapl1 deficiency promotes the expansion of tumour-infiltrating effector memory-like CD8<sup>+</sup> T cells and prevents their functional exhaustion, coupled with increased antitumour immunity and improved efficacy of adoptive T cell therapy. Dapl1 controls activation of NFATc2, a transcripti  ...[more]

Similar Datasets

| S-EPMC9951774 | biostudies-literature
| S-EPMC10902300 | biostudies-literature
| S-EPMC6921985 | biostudies-literature
| S-EPMC8600539 | biostudies-literature
| S-EPMC6377614 | biostudies-literature
| S-EPMC11393358 | biostudies-literature
| S-EPMC7292629 | biostudies-literature
| S-EPMC9452889 | biostudies-literature
| S-EPMC6713202 | biostudies-literature
| S-EPMC8977521 | biostudies-literature